NCT01890122 Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01879722 Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy Participants Status COMPLETED Phase PHASE1
NCT01861795 Observational Study in Preterm Neonates Who Are Sufficiently Stable on Non-Invasive Ventilatory Support Status COMPLETED Phase N/A
NCT01848210 Efficacy and Safety of Coumarin and Troxerutin in the Symptomatic Treatment of Chronic Venous Insufficiency Status COMPLETED Phase PHASE4
NCT01834274 Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT01829477 Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT01829464 TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT01765426 Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet Injector Status COMPLETED Phase PHASE1
NCT01763996 The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina Status COMPLETED Phase PHASE4
NCT01732692 Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel Preparation Status COMPLETED Phase PHASE3
NCT01728792 Impact of SC vs IM Administration of DENVax (TDV) on Safety and Immunogenicity Status COMPLETED Phase PHASE1
NCT01712490 A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma Status COMPLETED Phase PHASE3
NCT01701934 Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease Status TERMINATED Phase PHASE2
NCT01686711 A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322 Status COMPLETED Phase PHASE4